From December 12th to 14th, 2023, CEO Shunichi Kashida delivered a keynote speech and participated in a panel discussion at the 6th RNA-Targeted Drug Discovery & Development Summit in Boston.
Presentation Title: Comprehensive Interactome Profiling of RNA Library vs Compound Library Identifies Selective RNA Binders
Panel Discussion Title: What Makes a ‘Good’ RNA Target?
About xFOREST Therapeutics
xFOREST Therapeutics Co., Ltd. is a Kyoto-based biotechnology company engaged in the research and development of RNA-targeted small-molecule medicines. Building on its proprietary RNA structure analysis technology, xFOREST discovers selective small molecules for RNA targets that protein-first discovery cannot reach, and advances them into drug programs with partners.